| April 1 |
Bayer Appeals Invalidity Ruling on Its Yasmin Patent Appeal Will Be
Heard by the Federal Circuit |
| April 1 |
Senator Grassley Asks Merck, Schering-Plough Additional Questions
About Vytorin Study |
| April 1 |
Takeda Joins the HRP Initiative to Discover Biomarkers of High-Risk
Atherosclerotic Plaque |
| April 1 |
EU Advocate General Ruiz-jarabo Maintains That a Pharmaceutical
Company Holding a Dominant Position Which Refuses to Meet the
Orders of Wholesalers, in Order to Limit Parallel Trade, Engages in
Abusive Practice |
| April 1 |
Connecticut Attorney General Sues U.S. Food And Drug Administration
Over Oxycontin |
| April 1 |
Pfizer Successfully Completes Tender Offer for Shares of Encysive
Pharmaceuticals Inc. and Announces Subsequent Offer Period |
| April 1 |
Roche NimbleGen Launches NimbleGen Sequence Capture Technology for
Targeted Genome Resequencing |
| April 2 |
Further Data Needed to Determine Risk of Heart Attack with Abacavir |
| April 2 |
Consumer Reports Poll: Most Say TV Drug Ads Should Include Info on
How to Report Side Effects |
| April 2 |
FDA MedWatch- Relenza (zanamivir) Changes To The WARNINGS AND
PRECAUTIONS Sections Of Prescribing Information For Relenza About
Postmarketing Reports Of Neurologic And Behavioral Symptoms |
| April 3 |
Dendreon Announces $47 Million Registered Direct Offering |
| April 3 |
Zelnorm (tegaserod maleate) Information |
| April 3 |
Schering-Plough Launches Productivity Transformation Program To
Confront New Challenges |
| April 3 |
Eisai to Resume Clinical Study to Evaluate E2012 as a Potential
Next Generation Alzheimer's Disease Treatment |
| April 3 |
Chugai: Reinforcement of Structure for the European Sales Bases |
| April 4 |
Abraxis BioScience Acquires Shimoda Biotech and Platco Technologies |
| April 4 |
Takeda Wins Definitive Decision in Patent Infringement Litigation
on Appeal against an ANDA Filer for Generic Actos |
| April 4 |
Grassley Questions Increases in Drug Maker Rebates to Physicians
Prescribing Anti-Anemia Drugs |
| April 4 |
Forsteo Receives Approval from the European Commission for the
Treatment of Glucocorticoid-Induced Osteoporosis |
| April 7 |
Novartis to Acquire 25 Percent Minority Stake in Alcon from Nestle |
| April 7 |
Novartis to Acquire 25 Percent Minority Stake in Alcon from Nestle |
| April 7 |
Pfizer Reports Shares of Encysive Pharmaceuticals Inc. Tendered
Pursuant to Guaranteed Delivery Procedures |
| April 7 |
Keryx Biopharmaceuticals Announces Implementation of Strategic
Restructuring Plan |
| April 8 |
Repligen Announces Settlement with Bristol-Myers Squibb in Orencia
Lawsuit |
| April 8 |
Boehringer Ingelheim outpaces the market yet again in 2007 |
| April 8 |
Bristol-Myers Squibb Selects Isis Drug Targeting PCSK9 as
Development Candidate for Prevention and Treatment of
Cardiovascular Disease |
| April 8 |
Pfizer Extends Subsequent Offering Period of Tender Offer for
Shares of Encysive Pharmaceuticals |
| April 8 |
EFPIA Calls on EU Institutions to Reform Patient Information Rules
Without Further Delay |
| April 8 |
Alligator Blood May Put the Bite on Antibiotic-Resistant Infections |
| April 8 |
Durect Provides Update on Chronogesic Research Program |
| April 8 |
GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory
Reporting |
| April 9 |
Neurogen Announces $30.6 Million Financing to Advance Clinical
Development Programs |
| April 9 |
Nektar Terminates All Negotiations With Potential Partners for
Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in
Ongoing Clinical Studies of Inhaled Insulin Patients |
| April 9 |
Abraxis BioScience Announces Approval to Market Abraxane for
Metastatic Breast Cancer in Korea |
| April 9 |
VaxGen Restructures Following Termination of Proposed Merger |
| April 9 |
Novacea Receives Notification From Schering-Plough of Termination
of Collaboration Agreement |
| April 9 |
Pfizer Statement on Exubera Labeling Update in the United States |
| April 9 |
Harvard Announces Pioneering Collaboration with Merck & Co.,
Inc. to Advance Osteoporosis Research |
| April 10 |
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash
Tender Offer Valued at $8.8 Billion |
| April 10 |
Celera Grants License to Merck & Co., Inc. for Cancer Targets |
| April 10 |
ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to
Promotional Practices for Xibrom |
| April 10 |
FDA MedWatch-Exubera (insulin human rDNA origin) Inhalation
Powder-Prescribing Information Updated To Include Information About
Primary Lung Malignancies In Patients In Clinical Trials |
| April 10 |
FDA MedWatch-Neupro (rotigotine transdermal system)- Product
Recalled Due To The Formation Of Rotigotine Crystals In The Patches |
| April 10 |
Pharma's Direct-to-Consumer Marketing Continues Shift to Physician
Offices, Online Programs |
| April 10 |
ArQule Provides Clinical Update on E2F-1 Program |
| April 10 |
Biovail Announces Withdrawal of Legal Action by Eugene Melnyk |
| April 10 |
Pregnancy and Cancer Top the List Of the Most Commonly Searched
Health Conditions |
| April 10 |
FDA issues a Communication About an Ongoing Safety Review of
CellCept and Myfortic |
| April 10 |
DMA Forecasts $10.6 Billion in 2008 Pharmaceutical Sales via Direct
Marketing; New Report Focuses on Pharmaceutical Industry |
| April 10 |
Genentech Announces First Quarter 2008 Results |
| April 11 |
Status of the E2007 (perampanel) Development Program |
| April 11 |
AEterna Zentaris Announces Changes to its Management Team |
| April 11 |
Leslie J. Browne Resigns as President and Chief Executive Officer
of Pharmacopeia, Inc. |
| April 11 |
PDL BioPharma Declares $500 Million Special Cash Dividend and
Announces Plan to Separate Its Biotechnology Operations From Its
Antibody Humanization Royalty Assets |
| April 11 |
PDI Signs Promotion Agreement with Major Pharmaceutical Company |
| April 14 |
Alcon Announces Plans to Build Pharmaceutical Manufacturing Plant
in Singapore |
| April 14 |
Teva Announces Brussels Court Decision To Revoke MSD's European
Patent On Fosamax |
| April 14 |
Responses From Pharmaceutical Drug and Device Makers to Grassley
Request for Disclosure of Support for Continuing Medical Education |
| April 14 |
Vasogen Announces Implementation of Strategic Restructuring Plan |
| April 14 |
Nutra Pharma Acquires Remaining Interest in Biopharmaceutical Drug
Discovery Company - ReceptoPharm, Inc. |
| April 15 |
AstraZeneca Settles US Nexium Patent Litigation with Ranbaxy |
| April 15 |
Shire to Introduce a New UK Listed Holding Company |
| April 15 |
Roche Fully Acquires Privately-Owned Biotech Company Piramed |
| April 15 |
Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter
Reported EPS of $0.55 Including $0.35 Per Share Charge for
Licensing Payment |
| April 15 |
Johnson & Johnson Reports 2008 First-Quarter Results: |
| April 15 |
Pfizer Completes Tender Offer for Shares of Encysive
Pharmaceuticals Inc. |
| April 15 |
Ingenuity Systems and Pfizer Announce Strategic Partnership for
Pathway Analysis |
| April 15 |
IMS Health Reports Global Prescription Sales Grew 6.4 Percent in
2007, to $712 Billion |
| April 15 |
Statins May Help Reduce Blood Pressure |
| April 15 |
Risk of Death from Rofecoxib in Some Trials May Have Been
Misrepresented by Study Sponsor |
| April 15 |
JAMA Editorial: Impugning the Integrity of Medical Science —
the Adverse Effects of Industry Influence |
| April 15 |
Use of Ghostwriters, Guest Authors Appears Frequent for Studies
Involving Rofecoxib |
| April 15 |
Merck Responds to Journal of the American Medical Association
Articles |
| April 16 |
EMD Serono Announces Planned Investment of $50 Million in Research
Center in Massachusetts |
| April 16 |
Abbott Reports Double-Digit Sales and Earnings Growth in First
Quarter and Reaffirms Full-Year Growth Outlook |
| April 16 |
Consumers' Average Prescription Drug Copay Drops as Generic Drug
Use Grows |
| April 16 |
Linguamatics Announces Expansion of Strategic Collaboration with
Pfizer |
| April 16 |
Lilly to Streamline Indianapolis Manufacturing and Engineering
Operations |
| April 16 |
Consumers' Average Prescription Drug Copay Drops as Generic Drug
Use Grows |
| April 16 |
Covalence: Ethical Ranking 1st Quarter 2008 |
| April 16 |
Chemizon Announces a Second Expansion of Collaboration with Takeda |
| April 16 |
Chromos Provides Shareholder Update |
| April 16 |
Gilead Sciences Announces First Quarter 2008 Financial Results |
| April 17 |
FDA Issues "Review of Therapeutic Equivalence Generic Bupropion XL
300 Mg and Wellbutrin XL 300 Mg." |
| April 17 |
Baxter Reports Solid First Quarter Financial Results and Raises
Full-Year Outlook |
| April 17 |
Pfizer Reports First-Quarter 2008 Results; Reaffirms Full-Year 2008
Financial Guidance |
| April 17 |
GlaxoSmithKline and Regulus Therapeutics Form Strategic Alliance To
Develop MicroRNA Targeted Therapeutics to Treat Inflammatory
Diseases |
| April 17 |
Dynogen Pharmaceuticals and Apex Bioventures Mutually Terminate
Merger Agreement |
| April 17 |
Pfizer and AVANT Enter into Licensing and Development Agreement for
Novel Therapeutic Vaccine Candidate for Brain Cancer |
| April 17 |
Dainippon and Ono Discontinue Development for an Additional
Indication of Limaprost Alfadex |
| April 17 |
Roche Continues Solid Sales Growth in First Quarter of 2008 - Both
Divisions Significantly Outpace Their Markets |
| April 17 |
ViroPharma Announces Discontinuation of HCV-796 Development |
| April 17 |
Dynavax and Merck & Co., Inc. Update Status of Clinical Hold of
Investigational Vaccine Heplisav |
| April 17 |
Washington University in St. Louis and AstraZeneca Announce
Alzheimer's Research Collaboration |
| April 17 |
Growth Hormone is Used to Treat Twice as Many Short Boys Than Girls
in the U.S. and Asia; Gender Difference is Smaller in the Rest of
the World |
| April 17 |
Roche and the Institute for OneWorld Health Announce Research
Collaboration to Fight Neglected Diarrheal Diseases in Developing
Countries |
| April 17 |
Cangene Voluntarily Withdraws One Lot of its Vaccinia Immune
Globulin |
| April 17 |
HealthOpin III: Fearing Recession, Americans Cut Back on Healthcare
Spending |
| April 18 |
Federal Court in Canada Upholds Pfizer's Norvasc Patent; Decision
Prevents Launch of Generic Amlodipine Besylate Product by
Pharmascience until 2010 |
| April 18 |
Energy and Commerce Leaders Release Comprehensive Food and Drug
Safety Proposal |
| April 18 |
ISS/Risk Metrics Recommends Renovis Shareholders Vote for Merger
With Evotec |
| April 21 |
Novartis Reports Higher Sales and Earnings in First Quarter of 2008
Showing Healthcare Portfolio Well on the Way to New Growth Cycle |
| April 21 |
Pfizer Japan Receives Manufacturing and Marketing Authorization for
Sutent |
| April 21 |
PCMA: Court of Appeals Upholds Challenge to D.C.'s PBM
Fiduciary-Disclosure Law |
| April 21 |
Report on 750 New Medicines in Development for Cancer Released in
Baton Rouge |
| April 21 |
Vytorin Coverage with Leading Health Plans Revisited - See Uptake
of Generic Simvastatin and Crestor Without Need for Widespread
Formulary Changes |
| April 22 |
Children With ADHD Should Get Heart Tests Before Treatment with
Stimulant Drugs |
| April 22 |
FDA Warns Pfizer Over Viagra Video |
| April 22 |
Confidence in FDA Hits New Low, According to WSJ.com/Harris
Interactive Study |
| April 22 |
GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader
in 'Sirtuin' Research and Development |
| April 23 |
Biogen Idec Reports First Quarter 2008 Results |
| April 23 |
Schering-Plough Reports Financial Results for First Quarter of 2008 |
| April 23 |
GSK Reports Q1 Business Performance EPS of 25.6p |
| April 24 |
Former Bristol-Myers Squibb Senior Vice President Indicted for
Lying to the Federal Government About Popular Blood-Thinning Drug |
| April 24 |
AstraZeneca PLC First Quarter Results 2008 |
| April 24 |
Strong Double-Digit Net Sales Growth and Solid Earnings Growth
Highlight First Quarter for Bristol-Myers Squibb Company |
| April 24 |
Bayer Off to an Excellent Start in 2008 |
| April 24 |
Arana and Kyowa Hakko to Co-Develop Anti-Cancer Drug |
| April 24 |
Genentech Announces Decision in Contract Dispute |
| April 25 |
Following a Good Start to the Year Shire Reaffirms Full Year 2008
Financial Guidance |
| April 25 |
Solvay Pharmaceuticals S.A. Launches Friendly Bid to Acquire
Innogenetics |
| April 25 |
Astellas and CoMentis Sign Agreement to Collaborate on the
Research, Development and Commercialization of Beta-Secretase
Inhibitors |
| April 25 |
Abbott Annual Meeting Highlights Outstanding 2007 Results,
International Growth and Near-Term Pipeline |
| April 25 |
Pfizer Enters into Research Consortium to Expand Understanding of
Diabetes and Obesity Pathobiology |
| April 28 |
Kyowa Hakko Fiscal 2007 Operating Income up 28.3%: Sales and
Operating Income Exceed Plan Targets |
| April 28 |
U.S. Government Accepts $192 Million of Sanofi Pasteur H5N1 Bulk
Vaccine Antigen for Pandemic Stockpile |
| April 29 |
Takeda and Millennium Announce Early Termination of
Hart-Scott-Rodino Waiting Period |
| April 29 |
Hormone Therapy in Postmenopausal Women Associated with Increased
Risk of Stroke |
| April 30 |
FDA Embarks on Major Hiring Initiative for its Public Health
Mission |
| April 30 |
GSK Announces Changes to Corporate Executive Team |
| April 30 |
FDA Sends Warning Letter to Merck Over Manufacturing Practices |
| April 30 |
Sanofi-aventis: Encouraging First-Quarter 2008 Results Further
Positive Phase III Results for Eplivanserin |
